Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
8.08
-0.20 (-2.42%)
Nov 21, 2024, 1:49 PM EST - Market open
Olema Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$27.00
Upside
+234.16%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +271.29% | Nov 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +271.29% | Oct 24, 2024 |
JP Morgan | JP Morgan | Buy Maintains $33 → $31 | Buy | Maintains | $33 → $31 | +283.66% | Aug 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +271.29% | Aug 7, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $30 | Buy | Reiterates | $30 | +271.29% | Aug 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +271.29% | Jun 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +271.29% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $28 | Strong Buy | Maintains | $25 → $28 | +246.53% | May 9, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +197.03% | Apr 2, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $21 | Buy | Reiterates | $21 | +159.90% | Mar 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +209.41% | Mar 12, 2024 |
Citigroup | Citigroup | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +147.52% | Jan 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +246.53% | Oct 11, 2023 |
JP Morgan | JP Morgan | Buy Maintains $16 → $19 | Buy | Maintains | $16 → $19 | +135.15% | Sep 15, 2023 |
Oppenheimer | Oppenheimer | Buy Reiterates $21 | Buy | Reiterates | $21 | +159.90% | Sep 6, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $28 | Strong Buy | Maintains | $22 → $28 | +246.53% | Sep 5, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.